Ionis Enters $500m+ Agreement With Royalty Pharma To Help Fund Late-Stage Pipeline

Including Wholly Owned Assets

Animated image of green wads of money and gold coins on purple background
Ionis Needs The Cash To Advance Its Late-Stage Pipeline • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business